WW International Inc (WW) Q3 2024 Earnings Call Highlights: Navigating Challenges with ...

GuruFocus.com11-07

Revenue: $193 million for Q3 2024. Subscription Revenue: $191 million, down 6% year-over-year. Clinical Subscription Revenue: $19.1 million included in subscription revenues. Subscribers: 3.7 million ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2481548924?lang=en_US&edition=fundamental","thumbnail":"https://s.yimg.com/uu/api/res/1.2/nUtfIlvQwjSx3DU7xrfhEw--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/us.finance.gurufocus/daf79f7fbbf7219ba59e348c4b1d3980","is_english":true,"pubTime":"2024-11-07 15:10","share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","id":"2481548924","market":"us","top_or_hot":-1,"title":"WW International Inc (WW) Q3 2024 Earnings Call Highlights: Navigating Challenges with ...","media":"GuruFocus.com","content":"<div>\n<p>Revenue: $193 million for Q3 2024.\nSubscription Revenue: $191 million, down 6% year-over-year.\nClinical Subscription Revenue: $19.1 million included in subscription revenues.\nSubscribers: 3.7 million ...</p>\n\n<a href=\"https://finance.yahoo.com/news/ww-international-inc-ww-q3-071009291.html\">Source Link</a>\n\n</div>\n","source":"yahoofinance","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>WW International Inc (WW) Q3 2024 Earnings Call Highlights: Navigating Challenges with ...</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWW International Inc (WW) Q3 2024 Earnings Call Highlights: Navigating Challenges with ...\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-11-07 15:10 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/ww-international-inc-ww-q3-071009291.html><strong>GuruFocus.com</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Revenue: $193 million for Q3 2024.\nSubscription Revenue: $191 million, down 6% year-over-year.\nClinical Subscription Revenue: $19.1 million included in subscription revenues.\nSubscribers: 3.7 million ...</p>\n\n<a href=\"https://finance.yahoo.com/news/ww-international-inc-ww-q3-071009291.html\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"WW","symbol_name":"慧俪轻体","start_time":0,"source_url":"https://finance.yahoo.com/news/ww-international-inc-ww-q3-071009291.html","article_id":"2481548924","we_media_id":null,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/nUtfIlvQwjSx3DU7xrfhEw--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/us.finance.gurufocus/daf79f7fbbf7219ba59e348c4b1d3980"],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2481548924","pubTimestamp":1730963409,"sourceInfo":{"source_id":"yahoofinance","name":"雅虎金融"},"weMediaInfo":null,"summary":"Clinical Subscription Revenue: $19.1 million included in subscription revenues.Subscribers: 3.7 million at the end of Q3, a decline of 9% year-over-year.Clinical Subscribers: 78,000 at the end of Q3, representing 71% growth compared to prior year.Adjusted Gross Margin: 69.1%, up from 66.2% in the prior year.Adjusted G&A: $53 million, down 7% versus prior year.Adjusted Operating Income: $36 million, with an operating margin of 18.5%.Adjusted EPS: $0.24, including a $0.33 tax benefit.Cash Position: $57 million at the end of Q3.Net Debt to Adjusted EBITDAS Ratio: 10.4 times at the end of Q3.Full Year Revenue Guidance: At least $770 million.Full Year Adjusted Operating Income Guidance: At least $100 million.GuruFocus has detected 3 Warning Signs with WW.WW International Inc  has a comprehensive weight management platform that is uniquely positioned to meet members' needs across their weight journey.WW International Inc  is expanding its clinical offerings, including compounded semaglutide,","collect":0,"end_time":0,"defaultTopTitle":"yahoo.com","property":["earning"],"viewcount":null,"language":"en","relate_stocks":{"WW":"慧俪轻体"},"translate_title":"WW International Inc(WW)2024年第三季度收益看涨期权亮点：应对挑战...","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"WW":1},"content_text":"Revenue: $193 million for Q3 2024.\nSubscription Revenue: $191 million, down 6% year-over-year.\nClinical Subscription Revenue: $19.1 million included in subscription revenues.\nSubscribers: 3.7 million at the end of Q3, a decline of 9% year-over-year.\nClinical Subscribers: 78,000 at the end of Q3, representing 71% growth compared to prior year.\nAdjusted Gross Margin: 69.1%, up from 66.2% in the prior year.\nMarketing Expenses: $44 million, down 8% year-over-year.\nAdjusted G&A: $53 million, down 7% versus prior year.\nAdjusted Operating Income: $36 million, with an operating margin of 18.5%.\nAdjusted EBITDAS: $40 million.\nAdjusted EPS: $0.24, including a $0.33 tax benefit.\nCash Position: $57 million at the end of Q3.\nNet Debt to Adjusted EBITDAS Ratio: 10.4 times at the end of Q3.\nFull Year Revenue Guidance: At least $770 million.\nFull Year Adjusted Operating Income Guidance: At least $100 million.\nFull Year Adjusted EBITDAS Guidance: At least $150 million.\n\n\nWarning! GuruFocus has detected 3 Warning Signs with WW.\n\nRelease Date: November 06, 2024\nFor the complete transcript of the earnings call, please refer to the full earnings call transcript.\n Positive Points \n\nWW International Inc (NASDAQ:WW) has a comprehensive weight management platform that is uniquely positioned to meet members' needs across their weight journey.\nThe company has a strong scientific foundation with over 175 published papers of clinical research, proving the efficacy of its solutions.\nWW International Inc (NASDAQ:WW) has a highly engaged community, with members who participate in dynamic online and in-person communities, enhancing retention and weight loss success.\nThe company is leveraging its iconic and trusted brand, with plans to refresh its brand to engage both existing and potential future customers.\nWW International Inc (NASDAQ:WW) is expanding its clinical offerings, including compounded semaglutide, to address drug shortages and improve member retention.\n\n Negative Points \n\nThe company is facing significant challenges in changing the business trajectory due to industry disruptions and increased competition.\nThere is a high cost of customer acquisition, which has led to cautious marketing spending and impacted sign-up trends.\nWW International Inc (NASDAQ:WW) is dealing with drug shortages and insurance coverage issues, which are primary reasons for churn in its clinical subscribers.\nThe company has a significant debt burden, with a net debt to adjusted EBITDAS ratio of 10.4 times, prompting the appointment of advisers to evaluate capital structure options.\nDespite efforts to improve digital member journeys, the company acknowledges accumulated friction and complexity in its digital experience, which needs to be addressed.\n\n Q & A Highlights \nQ: Can you provide insights on the early success of the compounding launch and its impact on conversion, retention, and marketing? A: Tara Comonte, Interim President and CEO, noted the positive impact of the compounding launch, which led to the highest sign-up day in 2024. Donna Boyer, Chief Product Officer, added that the availability of compounded semaglutide resolved supply shortages, improving conversion rates. Heather Stark, CFO, mentioned that while the launch was successful, it is not expected to materially impact the overall business due to the proportion of clinic versus behavioral subscribers.\nQ: What are the key priorities ahead of the peak season to drive engagement and growth? A: Tara Comonte emphasized the focus on increasing awareness of the breadth and strength of Weight Watchers' offerings, including the clinical solutions. The company plans to refresh its brand to highlight community, joy, and livability, aiming to enhance engagement and awareness during the peak season.\nQ: Can you discuss the factors affecting retention in the clinical side of the business? A: Tara Comonte explained that cost and access are the primary reasons for churn among clinical subscribers. The introduction of compounded medications and improvements in the member experience have positively impacted retention rates.\nQ: How does Weight Watchers plan to integrate clinical and traditional programs for long-term member engagement? A: Tara Comonte highlighted the importance of integrating clinical solutions with Weight Watchers' nutritional programs. The goal is to support members both during and after medication use, ensuring long-term success and engagement with the brand.\nQ: How will the $100 million cost savings initiative impact the business, and what are the plans for reinvestment? A: Heather Stark stated that while the company is focused on profitability and liquidity, there will be necessary reinvestments to drive growth. The full run rate of cost savings is expected by the end of 2025, with strategic investments planned to leverage existing assets and support business growth.\nFor the complete transcript of the earnings call, please refer to the full earnings call transcript.This article first appeared on \nGuruFocus.","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2481548924"}